Dr. Cecelia Elizabeth Schmalbach, MD

Dr. Schmalbach practices at Temple University Hospital - Main Campus in Philadelphia, Pennsylvania.

Dr. Schmalbach's NPI, 1104804558, was assigned on January 5, 2006. Dr. Schmalbach graduated from Jefferson Medical College of Thomas Jefferson University in 1998. Dr. Schmalbach holds Pennsylvania license MD465783.

Dr. Schmalbach's primary practice is Temple University Hospital - Main Campus, at 3401-41 N Broad St, Philadelphia, PA 19140 in Philadelphia County. The practice phone is (215) 707-5303.

Dr. Schmalbach's primary practice is Temple University Hospital - Main Campus in Philadelphia, Pennsylvania. Dr. Schmalbach is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians. Dmand AI also links Dr. Schmalbach to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schmalbach practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Schmalbach's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Schmalbach's licenses on file in 4 states: Pennsylvania, Alabama, Indiana and Michigan.

CMS data shows 376 Medicare services from Dr. Schmalbach across 7 procedure codes in 2024, for 224 Medicare patients. Medicare paid $26,349 for them.

CMS counts 224 Medicare patients who saw Dr. Schmalbach in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schmalbach's median patient age at 70, with 43% women.

In 2020, Dr. Schmalbach wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $92 in total drug cost. In 2018, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Schmalbach for performance year 2024, reported as part of a group. Dr. Schmalbach accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schmalbach as offering telehealth. CMS counts 26 procedures of melanoma (skin cancer) excision by Dr. Schmalbach, more than 78% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 53 papers to Dr. Schmalbach, published from 2010 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Otolaryngology, Head and Neck Neoplasms and Carcinoma, Squamous Cell. Dr. Schmalbach has published most often in Otolaryngol Head Neck Surg. Dr. Schmalbach's most frequent co-authors are Eben L. Rosenthal, MD, Taha Z. Shipchandler, MD and Jonathan Y. Ting, MD.

CMS Open Payments shows 44 general payments to Dr. Schmalbach from 3 drug and device companies from 2016 to 2024. Accredited education speaker fees make up the largest share, 65% of the total. Synthes GmbH paid the most, $39,046.

Dr. Schmalbach graduated from Jefferson Medical College of Thomas Jefferson University in 1998.